PI3K-AKT-mTOR Pathway is Dominant over Androgen Receptor Signaling in Prostate Cancer Cells
Background: Androgen receptor (AR) and the phosphatidylinositol-3 kinase (PI3K) signaling are two of the most important pathways implicated in prostate cancer. Previous work has shown that there is crosstalk between these two pathways; however, there are conflicting findings and the molecular mechan...
Saved in:
| Main Authors: | Mari Kaarbø, Øyvind Løveseter Mikkelsen, Lene Malerød, Su Qu, Viola H. Lobert, Gulcan Akgul, Thomas Halvorsen, Gunhild M. Mælandsmo, Fahri Saatcioglu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | Cellular Oncology |
| Online Access: | http://dx.doi.org/10.3233/CLO-2009-0487 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
by: Mingyang Jiang, et al.
Published: (2025-08-01) -
AURKB and PI3K/AKT/mTOR pathways converge to regulate TERT expression
by: Grace Lim, et al.
Published: (2025-08-01) -
Research on the role and mechanism of the PI3K/Akt/mTOR signalling pathway in osteoporosis
by: Chuanlong Liu, et al.
Published: (2025-05-01) -
PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren’s Syndrome
by: Ping Zeng, et al.
Published: (2022-01-01)